Multiplicity corrections in life sciences: challenges and consequences
International Journal of Epidemiology · 11.06.2025 · 54 (4)
DOI: 10.1093/ije/dyaf098 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 27.06.2025. Verfasst von Otília Menyhárt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, Semmelweis University, H-1094 Budapest, Hungary. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research, Development, and Innovation Office, Hungarian Academy of Sciences and the Hungarian Scientific Research Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Bioinformatics, Semmelweis University, H-1094 Budapest, Hungary.
- Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Research Centre for Natural Sciences, H-1117 Budapest, Hungary.
- National Laboratory for Drug Research and Development, Research Centre for Natural Sciences, H-1117 Budapest, Hungary.
- Department of Biophysics, Medical School, University of Pecs, H-7624 Pecs, Hungary.
ORCID-Profile: Otília Menyhárt
Förderung
- National Research, Development, and Innovation Office
- Hungarian Academy of Sciences and the Hungarian Scientific Research Fund
Zitieren
APA
Menyhárt, O., & Győrffy, B. (2025). Multiplicity corrections in life sciences: challenges and consequences. International Journal of Epidemiology, 54(4). https://doi.org/10.1093/ije/dyaf098
Vancouver
Menyhárt O, Győrffy B. Multiplicity corrections in life sciences: challenges and consequences. International Journal of Epidemiology. 2025;54(4). doi:10.1093/ije/dyaf098
BibTeX
@article{Menyhrt2025,
author = {Menyhárt, Otília and Győrffy, Balázs},
title = {Multiplicity corrections in life sciences: challenges and consequences},
journal = {International Journal of Epidemiology},
year = {2025},
volume = {54},
number = {4},
doi = {10.1093/ije/dyaf098}
}
EUVIMED